N Engl J Med 2021 11;385(22):2059-2065
From the Departments of Pediatric Oncology (J.K., K.V.H., J.A.P., C.M.C., A.I., C.B.W., K.A.J., S.G.D.) and Medical Oncology (W.G.K.), Dana-Farber Cancer Institute, Harvard Medical School, the Divisions of Hematology and Oncology (J.K., J.A.P., M.M.H., K.A.J., S.G.D.) and Endocrinology (A.J.W.) and the Departments of Surgery (B.R.W.), Pathology (S.O.V.), and Radiology (S.D.V.), Boston Children's Hospital, Harvard Medical School, and the Manton Center for Orphan Disease Research and the Division of Genetics and Genomics, Boston Children's Hospital (J.A.M., J.L.) - all in Boston; Howard Hughes Medical Institute, Chevy Chase, MD (W.G.K.); and Merck, Kenilworth, NJ (R.F.P., N.J.Z.).
JAMA Netw Open 2021 Aug 2;4(8):e2121888. Epub 2021 Aug 2.
Division of Research, Kaiser Permanente Northern California, Oakland.
Pediatr Blood Cancer 2020 12 22;67(12):e28729. Epub 2020 Sep 22.
Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.